<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1819_S12_C12_p000-000_1P_v2</title>
		<link href="BCSC1819_S12_C12_p000-000_1P_v2-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1819_S12_C12_p000-000_1P_v2" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">CHAPTER</span><span class="cn-chap"> </span>12</p>
			<p class="chapter-title">Congenital and Stationary Retinal Disease</p>
			<p class="h1 ParaOverride-1">Color Vision (Cone System) Abnormalities</p>
			<div id="Chapt12_Top1">
			<p class="body-text--no-indent-">Patients may pres&#173;ent with color vision defects, or dyschromatopsia, that are &#173;either static or progressive. Static dyschromatopsia is usually, although not always, congenital. Whereas congenital color vision defects are stationary and usually affect both eyes equally, acquired color vision defects may be progressive and/or uniocular. This chapter describes the nonprogressive forms of color vision loss. For further discussion of optic neuropathies that may lead to acquired forms of vision loss, please refer to BCSC Section&#160;5, <span class="italic">Neuro-&#173;Ophthalmology.</span></p>
			<p class="h2">Congenital Color Deficiency</p>
			<p class="body-text--no-indent-">Congenital color vision defects are traditionally classified by an individual’s per&#173;for&#173;mance on color-&#173;matching tests. A person with normal color vision (<span class="italic">trichromatism,</span> or <span class="italic">trichromacy</span>) can match any colored light by varying a mixture of 3 different-&#173;colored lights, or primary colors (eg, a long-&#173;wavelength red, middle-&#173;wavelength green, and short-&#173;wavelength blue light).</p>
			<p class="body-text">Individuals with <span class="italic">anomalous trichromatism</span> make up the largest group of color-&#173;deficient persons; they include approximately 5%–6% of males. &#173;These individuals can also use 3 primary colors to match a given color; however, &#173;because 1 of their cone photopigments has an abnormal absorption spectrum, they use dif&#173;fer&#173;ent proportions of colors than &#173;those used by persons with normal color vision. Anomalous trichromacy ranges in severity. Some individuals have only a mild abnormality and may, for example, fail some of the subtle Ishihara test plates but have no trou&#173;ble naming colors or passing the less-&#173;sensitive screening tests such as the Farnsworth Panel D-15 hue test (see <span class="xref-local">Chapter&#160;3&#160;in this volume</span>). &#173;Others have poor color discrimination and may appear to have dichromacy on some of the color vision tests.</p>
			<p class="body-text">Hereditary congenital color vision defects are most frequently X-&#173;linked-&#173;recessive, red-&#173;green abnormalities; they affect 5%–8% of males and 0.5% of females. Acquired defects are more frequently of the blue-&#173;yellow, or tritan, variety and affect males and females equally. <span class="xref-table">&#173;Table&#160;12-1</span> shows the traditional classification of color vision deficits based on color-&#173;matching test results.</p>
			<p class="body-text">Individuals who need only 2 primary colors to make a color match have <span class="italic">dichromacy</span>. It is assumed that such individuals lack 1 of the cone photopigments. Approximately 2% of males have dichromacy.</p>
			<p class="body-text">An absence of color discrimination, or <span class="italic">achromatopsia,</span> means that any spectral color can be matched with any other solely by intensity adjustments. The congenital achromatopsias are disorders of photoreceptor function. Essentially, &#173;there are 2 forms of achromatopsia: (1) <span class="italic">rod monochromatism,</span> and (2) <span class="italic">S-&#173;cone monochromatism (blue-&#173;cone monochromatism).</span> Both disorders typically pres&#173;ent with congenital nystagmus, poor visual acuity, and photophobia. Electroretinography (ERG) testing helps differentiate achromatopsia from congenital motor nystagmus or ocular albinism, both of which are associated with normal cone ERGs (see <span class="xref-figure-local">Chapter&#160;3, </span><span class="xref-figure">Fig 3-&#173;2</span>).</p>
			<p class="body-text"><span class="italic">Rod monochromatism</span> (complete achromatopsia) is the most severe form; affected individuals have normal rod function but no detectable cone function and see the world in shades of gray. Patients may have full to partial expression of the disorder, with visual acuity ranging from 20/80 to 20/200. Nystagmus is usually pres&#173;ent in childhood and may improve with age. Characteristically, the ERG pattern in patients with rod monochromatism shows an absence of cone-&#173;derived responses and normal rod responses. Dark adaptometry shows no cone plateau and no cone–&#173;rod break. The disorder exhibits autosomal-&#173;recessive inheritance.</p>
			<p class="body-text">In <span class="italic">S-&#173;cone</span> (or <span class="italic">blue-&#173;cone</span>) <span class="italic">monochromatism,</span> the function of rods and S cones is normal, but L-&#173; and M-&#173;cone function is absent. The condition is usually X-&#173;linked and can be difficult to distinguish clinically from rod monochromatism in the absence of a &#173;family history or results from specialized color or ERG testing. Individuals with <br />S-&#173;cone monochromatism exhibit preserved S-&#173;cone ERG responses, severely reduced cone flicker ERGs, and normal rod ERGs. &#173;These individuals typically have a visual acuity of approximately 20/80, which is better than the visual acuity found in individuals with typical rod monochromatism.</p>
			<p class="reference--non-journal--first">Dingcai&#160;C. Color vision and night vision. In: Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, eds. <span class="italic">Ryan’s Ret&#173;i&#173;na.</span> Vol 1. 6th&#160;ed. Philadelphia: Elsevier/Saunders; 2018:<br />325–339.</p>
			<p class="reference--non-journal--last ParaOverride-2">Wu DM, Amani AF. Abnormalities of cone and rod function. In: Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, eds. <span class="italic">Ryan’s </span><span class="italic">Ret&#173;i&#173;na.</span> Vol 2. 6th&#160;ed. Philadelphia: Elsevier/Saunders; 2018:1006–1017.</p>
			</div>
			<p class="h1 ParaOverride-3">Night Vision (Rod System) Abnormalities</p>
			<div id="Chapt12_Top2">
			<p class="h2-h1">Congenital Night-Blinding Disorders With Normal Fundi</p>
			<p class="body-text--no-indent-"><span class="italic">Congenital stationary night blindness</span> (CSNB) is a nonprogressive disorder of night vision. CSNB has 3 ge&#173;ne&#173;tic subtypes:</p>
			<p class="numbered-list-first">1.&#9;X-&#173;linked (most common)</p>
			<p class="numbered-list-mid">2.&#9;autosomal recessive</p>
			<p class="numbered-list-last">3.&#9;autosomal dominant (rare)</p>
			<p class="body-text">Snellen visual acuities of patients with CSNB range from normal to occasionally as poor as 20/200, but most cases of decreased vision are associated with significant myopia. The appearance of the fundus is usually normal, except for myopic changes in some cases. Patients commonly pres&#173;ent with difficulty with night vision; nystagmus and reduced visual acuity may also be presenting symptoms. Some CSNB patients never report nyctalopia (night blindness), perhaps &#173;because they are accustomed to it. Some patients may have a paradoxical pupillary response, in which the pupil dilates when the ambient light dims. Dark-adaptometry curves reveal markedly reduced responses (Fig 12-1).</p>
			<p class="body-text">Electroretinography is impor&#173;tant in the diagnosis of CSNB. The most common ERG pattern seen in patients with CSNB is the <span class="italic">negative</span> ERG (the Schubert-&#173;Bornschein form of CSNB), in which the bright-&#173;flash, dark-&#173;adapted ERG has a normal (or near-&#173;normal) a-&#173;wave but a markedly reduced b-&#173;wave. The normal a-&#173;wave excludes significant rod photoreceptor dysfunction, and the result thus facilitates the differentiation of CSNB from the potentially blinding disorder retinitis pigmentosa (RP; see <span class="xref-local">Chapter&#160;3</span>).</p>
			<p class="body-text">X-&#173;linked CSNB has been categorized into 2 types: “complete” and “incomplete.” Patients with complete CSNB (cCSNB) have an undetectable rod-&#173;specific, dim-&#173;flash, dark-&#173;adapted ERG and psychophysical thresholds that are mediated by cones. Patients with incomplete CSNB (iCSNB) have some detectable rod function on ERG and an elevated dark-&#173;adaptation final threshold (<span class="xref-figure">Fig 12-2</span>). The differential diagnosis of CSNB includes melanoma-&#173;associated retinopathy (MAR), which demonstrates an identical ERG pattern to CSNB, but which usually pres&#173;ents with acquired night blindness and shimmering photopsias.</p>
			<p class="h2">Congenital Night-&#173;Blinding Disorders With Fundus Abnormality</p>
			<p class="body-text--no-indent-"><span class="italic">Fundus albipunctatus</span> results from a mutation in <span class="italic">RDH5</span> (12q13–&#173;q14). <span class="italic">RDH5</span> encodes 11-&#173;<span class="italic">cis</span>-&#173;retinol dehydrogenase, a microsomal enzyme in the ret&#173;i&#173;nal pigment epithelium (RPE) that is involved in the regeneration of rhodopsin. Patients with fundus albipunctatus have very delayed rhodopsin regeneration, and although levels eventually normalize, the pro&#173;cess may require many hours in the dark. Affected individuals are night blind from birth and usually exhibit yellow-&#173;white dots in the posterior pole extending into the midperiphery, but sparing the fovea (<span class="xref-figure">Fig 12-&#173;3</span>). ERG responses commonly show a cone-&#173;isolated ret&#173;ina pattern, with undetectable rod-&#173;specific ERG, and a severely reduced bright-&#173;flash dark-&#173;adapted ERG (arising in dark-&#173;adapted cones) that normalizes with sufficiently extended dark adaptation. Some patients may have a normal fundus but characteristic ERG findings and molecular confirmation of the mutation; visual acuity and color vision are usually good in &#173;these patients.</p>
			<p class="body-text">The differential diagnosis of fundus albipunctatus includes <span class="italic">retinitis punctata albescens,</span> a disorder related to mutation in <span class="italic">RLBP1,</span> which encodes cellular retinaldehyde-&#173;binding protein. In this condition, which is a progressive rod–&#173;cone dystrophy, the white dots may be finer than &#173;those of <span class="italic">fundus albipunctatus</span>, and &#173;there may be attenuation of the ret&#173;i&#173;nal vessels. ERG responses are usually very abnormal; although they show some recovery with extended dark adaptation, they do not normalize.</p>
			<p class="body-text">Patients with <span class="italic">Oguchi disease</span> are also night blind from birth. This condition is due to &#173;either a mutation in the gene <span class="italic">SAG</span> (2q37), which encodes arrestin, or in <span class="italic">GRK1</span> (13q34), which encodes rhodopsin kinase. This very rare disorder is most common in Japa&#173;nese patients. The fundus in eyes with Oguchi disease is normal &#173;after dark adaptation but shows a peculiar yellow iridescent sheen alteration &#173;after even brief exposure to light (the <span class="italic">Mizuo-&#173;Nakamura phenomenon;</span> <span class="xref-figure">Fig 12-</span>&#173;<span class="xref-figure">4</span>).</p>
			<p class="reference--non-journal--first">Cukras CA, Zein WM, Caruso RC, Sieving PA. Progressive and “stationary” inherited ret&#173;i&#173;nal degenerations. In: Yanoff M, Duker JS, eds. <span class="italic">Ophthalmology.</span> 4th&#160;ed. St.&#160;Louis: Elsevier/Saunders; 2013:480–490.</p>
			<p class="reference--journal--last">Zeitz C, Robson AG, Audo&#160;I. Congenital stationary night blindness: an analy&#173;sis and update of genotype-&#173;phenotype correlations and pathogenic mechanisms. <span class="italic">Prog Retin Eye Res.</span> 2015;<br />45:58–110.</p>
		</div>
		</div>
		<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
			<table id="table001" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table _1-BCSC-table-title-" colspan="5">
							<p class="table-title"><span class="table-number">Table&#160;12-1</span> Classification and Male-&#173;Population Incidence of Color Vision Defects</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table table-column-head CellOverride-1">
							<p class="table-column-head">Color Vision</p>
						</td>
						<td class="Basic-Table table-column-head CellOverride-1" />
						<td class="Basic-Table table-column-head CellOverride-1">
							<p class="table-column-head">Inheritance</p>
						</td>
						<td class="Basic-Table table-column-head CellOverride-1" />
						<td class="Basic-Table table-column-head CellOverride-1">
							<p class="table-column-head">Incidence in Male Population (%)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-body"><span class="bold-table">Hereditary</span></p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body"><span class="table-italic">Trichromatism</span></p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Normal</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">–&#173;</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">92.0</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Deuteranomalous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">XR</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">5.0</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Protanomalous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">XR</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">1.0</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Tritanomalous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">AD</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">0.0001</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body"><span class="table-italic">Dichromatism</span></p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Deuteranomalous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">XR</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">1.0</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Protanomalous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">XR</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">1.0</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Tritanomalous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">AD</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">0.001</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body"><span class="table-italic">Achromatopsia (monochromatism)</span></p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Typical (rod monochromatism)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">AR</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-6">0.0001</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-4">Aty&#173;pi&#173;cal (blue-&#173;cone monochromatism)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">XR</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">Unknown</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="bold-table">Acquired</span></p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Tritanomalous (blue-&#173;yellow)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">Unknown</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body ParaOverride-5">Unknown</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-5 _idGenCellOverride-1">
							<p class="table-body">Protanomalous-&#173;deuteranomalous (red-&#173;green)</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-5 _idGenCellOverride-1" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-5 _idGenCellOverride-1">
							<p class="table-body ParaOverride-5">Unknown</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-5 _idGenCellOverride-1" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-5 _idGenCellOverride-1">
							<p class="table-body ParaOverride-5">Unknown</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-6 _idGenCellOverride-2" colspan="5">
							<p class="table-source-note">AD <span class="table-footnote-symbol">=</span> autosomal dominant; AR <span class="table-footnote-symbol">=</span> autosomal recessive; XR <span class="table-footnote-symbol">=</span> X-&#173;linked recessive.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer002" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1819_S12_C12_p000-000_1P_v2-web-resources/image/AAX-8263.png" alt="" />
			</div>
		</div>
		<div id="_idContainer003" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 12-1</span> Dark-adaptometry curve in congenital stationary night blindness (CSNB). The dark-adaptometry curve of this patient <span class="figure-caption-italic">(dotted curve)</span> with CSNB shows no rod adaptation. <span class="figure-caption-italic">Dashed curve</span> indicates normal response.<span class="figure-source-note"> (Used with permission from Ripps H. Night blindness revi</span><span class="figure-source-note">s</span><span class="figure-source-note">ited: from man to molecules. Proctor lecture. </span><span class="figure-source-emphasis">Invest Ophthalmol Vis Sci.</span><span class="figure-source-note"> 1982;23(5):588–609.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006">
				<div id="_idContainer004" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S12_C12_p000-000_1P_v2-web-resources/image/AAX-8264.png" alt="" />
				</div>
				<div id="_idContainer005" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 12-2</span> Electroretinography (ERG) patterns of on- and off-responses in CSNB. The stimulus has a 200-millisecond (ms) duration to enable independent recording of the ERG responses to onset and offset. <span class="figure-caption-bold">A,</span> The pattern of a patient with “complete” CSNB shows a negative-waveform&#173; on-response but a normal off-response. <span class="figure-caption-bold">B,</span> The pattern of a patient with “incomplete” CSNB shows both on- and off-response abnormalities. <span class="figure-caption-bold">C,</span> Pattern of a subject with normal responses. <span class="figure-source-note">(Courtesy of Graham E. Holder, PhD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer007" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1819_S12_C12_p000-000_1P_v2-web-resources/image/AAX-9935.png" alt="" />
			</div>
		</div>
		<div id="_idContainer008" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 12-3</span> Fundus photographs and fundus autofluorescence images of a patient with fundus albipunctatus, showing multiple spots of unknown material scattered primarily throughout the deep retina. <span class="figure-source-note">(Used with permission from Sergouniotis PI, Sohn EH, Li Z, et al. Phenotypic variability in RDH5 retinopathy (fundus albipunctatus). </span><span class="figure-source-emphasis">Ophthalmology.</span><span class="figure-source-note"> 2011;118(8):1661–1670.) </span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer011">
				<div id="_idContainer009" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S12_C12_p000-000_1P_v2-web-resources/image/AAX-0682.png" alt="" />
				</div>
				<div id="_idContainer010" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 12-4</span> Fundus photographs of eyes with the Mizuo-Nakamura phenomenon. The fundus of this patient with X-linked cone dystrophy is unremarkable in a dark-adapted state <span class="figure-caption-italic">(right)</span> but has a yellow iridescent sheen after exposure to light <span class="figure-caption-italic">(left)</span>.</p>
				</div>
			</div>
		</div>
	</body>
</html>
